LAS VEGAS--(BUSINESS WIRE)--April 4, 2006--Samaritan Pharmaceuticals, Inc. (AMEX:LIV - News) is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification by the National Pharmaceuticals Organization, (EOF) for a new marketing authorization for Amphocil in Greece.
